SAMABRIVA BIOMANUFACTURING

Liège ·KBO/BCE: BE 1002.863.501

Loading dossier…

Metric	This company	Sector median	Position in the sector
Solvency	-86.3%	42.0%	better than 5% of 184 sector peers
Net result	€-722k	€164k	better than 5% of 184 sector peers
Equity	€-934k	€1.23M	better than 5% of 184 sector peers
Gross operating margin	€-473k	€186k	better than 5% of 98 sector peers
Staff costs	€130k	€777k	higher than 18% of 140 sector peers

Line item	Code	2025
Balance sheet, Assets
TOTAL ASSETS	20/58	€1.08M
Fixed assets	21/28	€644k
Intangible fixed assets	21	€530k
Tangible fixed assets	22/27	€114k
Current assets	29/58	€438k
Amounts receivable within one year	40/41	€39k
Cash & bank	54/58	€393k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€1.08M
Equity	10/15	€-934k
Contributions / capital	10/11	€150k
Accumulated profits (losses)	14	€-1.27M
Amounts payable	17/49	€2.02M
Amounts payable after one year	17	€1.80M
Amounts payable within one year	42/48	€131k
Trade debts payable within one year	44	€107k
Income statement
Gross operating margin	9900	€-473k
Operating result	9901	€-636k
Financial income	75	€5k
Financial charges	65	€91k
Result before taxes	9903	€-722k
Income taxes	67/77	€250
Net result for the period	9904	€-722k
Result to be appropriated	9905	€-722k

NACE primary	Groothandel in farmaceutische en medische artikelen(46460)
Legal form	Public limited company(014)
Incorporation	30-11-2023
Status	Active
Postal code	4031

Summary